SFX by Ex Libris Inc.

Title:	PrimPol prevents APOBEC/AID family mediated DNA mutagenesis
Source:	Nucleic Acids Research [0305-1048] Pilzecker, B yr:2016

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	German, J. "Bloom's syndrome. XX. The first 100 cancers." Cancer genetics and cytogenetics 93.1 (1996): 100-6.
description	2.	Seplyarskiy, Vladimir B. "APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication." Genome research 26.2 (2016): 174-182.
description	3.	Dommergues, B. "Occurrence of myeloproliferative disorder in patients with Noonan syndrome." The journal of pediatrics 130.6 (1997): 885-889.
description	4.	"Abstract P5-06-03: A solution to the APOBEC mutation paradox in breast cancer." Cancer research. 77.4 Supplement.
description	5.	Bugreev, D. V., Yu, X., Egelman, E. H., Mazin, A., Alexander V V. "Novel pro- and anti-recombination activities of the Bloom's syndrome helicase." Genes & development 21.23 (2007): 3085-94.
description	6.	Thomas, E R A R. "Surveillance and treatment of malignancy in Bloom syndrome." Clinical Oncology 20.5 (2008): 375-9.
description	7.	Hirschhorn, R. "In vivo reversion to normal of inherited mutations in humans." Journal of medical genetics 40.10 (2003): 721-728.
description	8.	Nilius, B. "Transient receptor potential cation channels in disease." Physiological reviews 87.1 (2006): 165-217.
description	9.	Bastida, P. "Myeloproliferative disorder in Noonan syndrome." Journal of pediatric hematology/oncology 33.1 (2011): -5.
description	10.	Schultz, M. "A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada." British journal of haematology 106.4 (1999): 1027-32.
description	11.	Frohling, S.. "CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations." Journal of clinical oncology 22.4: 624-633.
description	12.	Lifton, Richard M. "Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti." The Journal of clinical investigation 125.4 (2015): 1703-1707.
description	13.	Izakovic, J. "Bloom syndrome." International journal of dermatology 53.7 (2014): 798-802.
description	14.	Shiraishi, Y. "P53 mutation in fresh lymphocytes, B-lymphoblastoid cell lines and their transformed cell lines originating from Bloom syndrome patients." Cancer Genetics and Cytogenetics 68.1 (1993): 70-.
description	15.	Sawitsky, A. "Chromosomal breakage and acute leukemia in congenital telangiectatic erythema and stunted growth." Annals of internal medicine 65.3 (1966): 487-95.
description	16.	Gregory, J J. "Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells." Proceedings of the National Academy of Sciences of the United States of America 98.5 (2001): 2532-2537.
description	17.	German, J. "Bloom syndrome: a Mendelian prototype of somatic mutational disease." Medicine 72.6 (1993): 393-406.
description	18.	Wu, L. "Role of the BLM helicase in replication fork management." DNA repair 6.7 (2007): 936-44.
description	19.	Jonkman, Marcel F F. "Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3." The journal of clinical investigation 117.5 (2007): 1240-8.
description	20.	Ashton, G H S H. "Kindler syndrome." Clinical and experimental dermatology 29.2 (2004): 116-21.